SSII

The article profiles two rare microcap companies generating majority sales outside the US: SS Innovations International (SSII), a surgical robotics company with 87% of sales from India showing strong 39.4% YOY revenue growth but facing cash burn issues, and Iveda Solutions (IVDA), an AI-driven smart city technology provider with 91% of sales from Taiwan that generates lumpy, project-driven revenue from government contracts.

Zacks Investment Research initiated coverage of SS Innovations International (SSII) with a Neutral recommendation. The surgical robotics company shows strong growth in system installations (up 42% to 238 units) and procedure volumes (up 79% to 14,103), with revenues increasing to $25 million in H1 2026. However, persistent operating losses of $6.2 million, financing needs, regulatory uncertainties, and competition from established manufacturers temper the outlook.